Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease, NeuroImage: Clinical, vol.2, issue.1 ,
DOI : 10.1016/j.nicl.2013.03.014
The aloid hhpothesis of Alzheiee's disease: ppogess aad ppoles on the road to therapeutics Moleeulaa ehaisss fo Alzheiee's disease: implications for neuroimaging and therapeutics, Science. J. Neurochem, vol.297, pp.97-1700, 2002. ,
Clinico-pathologic studies in deeeetia: odeeeted suujeets ith pathologiall ofied Alzheiee's disease, Neurology, pp.38-1682, 1988. ,
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques Frequency of stages of Alzheimer-related lesions in different age categories Tangles and plaques in nondemented aging and « preclinical » Alzheiee's disease Imaging brain aaloid i Alzheiee's disease with Pittsburgh Compound-B, Preclinical properties of 18F- AV-45: a PET agent for Abeta plaques in the brain, pp.50-1887, 1988. ,
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18), Journal of Nuclear Medicine, vol.51, issue.6, pp.51-913, 2010. ,
DOI : 10.2967/jnumed.109.069088
Cliial aaloid iagig i Alzheiee's disease, Laaet Neuuol, pp.667-670, 2011. ,
PET of Brain Amyloid and Tau in Mild Cognitive Impairment, New England Journal of Medicine, vol.355, issue.25, pp.355-2652, 2006. ,
DOI : 10.1056/NEJMoa054625
Amyloid imaging as a biomarker for cerebral ??-amyloidosis and risk prediction for Alzheimer dementia, Neurobiology of Aging, vol.32, issue.1, pp.20-36, 2011. ,
DOI : 10.1016/j.neurobiolaging.2011.09.006
Amyloid load and eeeal attoph i Alzheiee's disease: aa C-PIB positron emission tomography study, Ann. Neurol, pp.60-145, 2006. ,
[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease, Neurology, vol.67, issue.3, pp.67-446, 2006. ,
DOI : 10.1212/01.wnl.0000228230.26044.a4
Imaging beta-amyloid burden in aging and dementia, Neurology, pp.68-1718, 2007. ,
Abeta amyloid deposition in the language system and how the brain responds, p.130, 2007. ,
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly, Archives of Neurology, vol.65, issue.11, pp.65-1509, 2008. ,
DOI : 10.1001/archneur.65.11.1509
11C PiB and sttuutuual MRI ppoide opleeeetaaa ifoatio i iagig of Alzheiee's disease aad amnestic mild cognitive impairment, pp.131-665, 2008. ,
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition, Arch. Neurol, pp.66-1476, 2009. ,
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals, Cerebral Cortex, vol.19, issue.3, pp.497-510, 2009. ,
DOI : 10.1093/cercor/bhn113
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia, Neurology, pp.74-121, 2010. ,
Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging, Journal of Alzheimer's Disease, vol.21, issue.3, pp.995-1003, 2010. ,
DOI : 10.3233/JAD-2010-100222
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging, Ann. Neurol, pp.67-122, 2010. ,
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study, Neurology, vol.73, issue.10, pp.73-754, 2009. ,
DOI : 10.1212/WNL.0b013e3181b23564
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core, Alzheimer's & Dementia, vol.6, issue.3, pp.221-229, 2010. ,
DOI : 10.1016/j.jalz.2010.03.003
PET imaging of brain amyloid in dementia: a review, International Journal of Geriatric Psychiatry, vol.46, issue.(Suppl 2), pp.991-999, 2011. ,
DOI : 10.1002/gps.2640
18F- flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial, Ann. Neurol, pp.68-319, 2010. ,
Copaaiso of 11C-PiB and 18F-florbetaben for A? iagig i ageig aad Alzheiee's disease, Eu. J. Nul. Med. Mol. Imaging, pp.39-983, 2012. ,
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Soiet of Nulea Mediie aad Moleulaa IIagig, aad the Alzheiee's Assoiatio, Alzheimers Dement, 2013. ,
Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant, NeuroImage, vol.59, issue.2, pp.59-1152, 2012. ,
DOI : 10.1016/j.neuroimage.2011.07.098
Teehhial aspeets of aloid iagig fo Alzheiee's disease, Alzheimers Res Ther, vol.3, issue.25, 2011. ,
Regional dynamics of amyloid-? depositio i health eldeel, ild ogitie ipaieet aad Alzheiee's disease: a voxelwise PiB-PET longitudinal study, pp.135-2126, 2012. ,
Florbetapir PET analysis of amyloid-?? deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study, The Lancet Neurology, vol.11, issue.12, pp.1057-1065, 2012. ,
DOI : 10.1016/S1474-4422(12)70227-2
Can targetto-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?, Neuroimage, pp.60-1716, 2012. ,
Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology, vol.79, issue.15, pp.79-1570, 2012. ,
DOI : 10.1212/WNL.0b013e31826e2696
Fibrillar amyloid-beta burden in ogitiel oal people at leeels of geeeti isk fo Alzheiee's disease ,
Longitudinal assessment of A?? and cognition in aging and Alzheimer disease, Annals of Neurology, vol.29, issue.1, pp.69-181, 2011. ,
DOI : 10.1002/ana.22248
APOE modifies the association between A? load and cognition in cognitively normal older adults, Neurology, pp.78-232, 2012. ,
Apolipoprotein E ??4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease, Neurobiology of Aging, vol.34, issue.1, pp.1-12, 2013. ,
DOI : 10.1016/j.neurobiolaging.2012.04.017
Amyloid-?? assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study, Neurology, vol.79, issue.16, 2012. ,
DOI : 10.1212/WNL.0b013e3182661f74
Subjective Cognition and Amyloid Deposition Imaging, Archives of Neurology, vol.69, issue.2, pp.69-223, 2012. ,
DOI : 10.1001/archneurol.2011.666
URL : https://hal.archives-ouvertes.fr/inserm-00728999
Subjective cognitive complaints and amyloid burden in cognitively normal older individuals, Neuropsychologia, vol.50, issue.12, pp.50-2880, 2012. ,
DOI : 10.1016/j.neuropsychologia.2012.08.011
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease, Ann. Neurol, pp.67-317, 2010. ,
Increased fibrillar amyloid-?? burden in normal individuals with a family history of late-onset Alzheimer's, Proceedings of the National Academy of Sciences, vol.107, issue.13, pp.5949-5954, 2010. ,
DOI : 10.1073/pnas.0914141107
Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study, Archives of Neurology, vol.68, issue.10, pp.68-1313, 2011. ,
DOI : 10.1001/archneurol.2011.208
Early detection of Alzheimer disease: 11C-PiB PET in twins discordant for cognitive impairment, Neurology, vol.77, issue.5, pp.77-453, 2011. ,
DOI : 10.1212/WNL.0b013e318225118e
Cognition, reserve and amyloid deposition in normal aging, Annals of Neurology, pp.67-353, 2010. ,
DOI : 10.1002/ana.21904
Assoiatio of lifetime cognitive engagement and low ?-amyloid deposition, Arch. Neurol, pp.69-623, 2012. ,
Exercise aad Alzheiee's disease ioaakees i ogitiel oal oldee adults, AA. Neuol, pp.311-318 ,
Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition, Arch. Neurol, pp.69-636, 2012. ,
What is cognitive reserve? Theory and research application of the reserve concept, Journal of the International Neuropsychological Society, vol.8, issue.03, pp.448-460, 2002. ,
DOI : 10.1017/S1355617702813248
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees, Journal of Neuroscience, vol.27, issue.23, pp.27-6174, 2007. ,
DOI : 10.1523/JNEUROSCI.0730-07.2007
High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types, Arch. Neurol, pp.66-1537, 2009. ,
Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers, Brain, vol.134, issue.1, pp.134-293, 2011. ,
DOI : 10.1093/brain/awq310
Positron emission tomography in at risk patients and in the progression of ild ogitie ipaiet to Alzheiee's disease, J. Alzheiees Dis ,
Alzheiee's disease: geeeti asis aad aloid imaging as endophenotype, Q J Nucl Med Mol Imaging, pp.55-225, 2011. ,
Clinical and biomarker changes in dominantly inheeited Alzheiee's disease, N. Egl, J. Med, pp.795-804 ,
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study, The Lancet Neurology, vol.11, issue.12, pp.1048-1056, 2012. ,
DOI : 10.1016/S1474-4422(12)70228-4
Bioakees of Alzheiee's disease, Neuuoiol. Dis, vol.35, pp.128-140, 2009. ,
The clinical use of structural MRI in Alzheimer disease, Nature Reviews Neurology, vol.15, issue.2, pp.67-77, 2010. ,
DOI : 10.1038/nrneurol.2009.215
Hypothetical model of dddai ioaakees of the Alzheiee's pathologial assade, Laaet Neuol ,
Alzheiee's disease: ppogess i ppeditio ,
The Alzheiee's disease euuoiagig iitiatie: ppogess epot aad futuue plaas, Alzheiees Dement, pp.202-211, 2010. ,
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects, pp.132-1310, 2009. ,
Aloid deposition is associated with impaired default network function in older persons without dementia, pp.63-178, 2009. ,
Toward a multifactorial model of Alzheimer disease, Neurobiology of Aging, vol.33, issue.10, pp.33-2262, 2012. ,
DOI : 10.1016/j.neurobiolaging.2011.11.029
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB, Neurology, vol.74, issue.10, pp.74-807, 2010. ,
DOI : 10.1212/WNL.0b013e3181d3e3e9
Amyloid imaging and memory change for prediction of cognitive impairment, Alzheimer's Research & Therapy, vol.3, issue.1, 2011. ,
DOI : 10.1186/alzrt62
Cerebrovascular disease, beta-amyloid, and cognition in aging, Neurobiology of Aging, vol.33, issue.5, pp.33-2012 ,
DOI : 10.1016/j.neurobiolaging.2011.10.001
Beta-amyloid imaging and memory in non-deeeted idiiduals: eideeee fo ppeeliial Alzheiee's disease, BBai, pp.130-2837, 2007. ,
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheiee's disease ,
Face-name associative memory performance is related to amyloid burden in normal elderly, Neuropsychologia, vol.49, issue.9, pp.49-2776, 2011. ,
DOI : 10.1016/j.neuropsychologia.2011.06.006
Covarying alterations in A?? deposition, glucose metabolism, and gray matter volume in cognitively normal elderly, Human Brain Mapping, vol.29, issue.Part 4, 2012. ,
DOI : 10.1002/hbm.22173
Effects of age and ??-amyloid on cognitive changes in normal elderly people, Neurobiology of Aging, vol.33, issue.12, pp.33-2746, 2012. ,
DOI : 10.1016/j.neurobiolaging.2012.02.008
Cognition and betaaaloid i peliial Alzheiee's disease: data ffo the AIBL stud, Neuopsshologia, pp.2384-2390, 2011. ,
Larger temporal volume in elderly with high versus low beta-amyloid deposition, Brain, vol.133, issue.11, pp.133-3349, 2010. ,
DOI : 10.1093/brain/awq187
Region-Specific Hierarchy between Atrophy, Hypometabolism, and ?-Amyloid (A? Load i Alzheiee's Disease Dementia, J. Neurosci, pp.32-16265, 2012. ,
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden, J. Neurosci, pp.29-12686, 2009. ,
Amyloid-?? associated cortical thinning in clinically normal elderly, Annals of Neurology, vol.9, issue.6, pp.69-1032, 2011. ,
DOI : 10.1002/ana.22333
Direct voxel-ased opaaiso etteee ggee attee hpoetaaolis aad atoph i Alzheiee's disease, pp.131-60, 2008. ,
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease, Archives of Neurology, vol.66, issue.12, pp.66-1469, 2009. ,
DOI : 10.1001/archneurol.2009.269
Accelerated cortical atrophy in cognitively normal elderly with high ??-amyloid deposition, Neurology, vol.78, issue.7, pp.78-477, 2012. ,
DOI : 10.1212/WNL.0b013e318246d67a
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls, Neurology, vol.73, issue.15, pp.73-1186, 2009. ,
DOI : 10.1212/WNL.0b013e3181bacf1b
Spatial patterns of brain amyloidbeta burden and atrophy rate associations in mild cognitive impairment, p.134, 2011. ,
Alzheiee's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition, pp.45-645, 2009. ,
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans, Neurobiology of Aging, vol.31, issue.8, pp.31-1463, 2010. ,
DOI : 10.1016/j.neurobiolaging.2010.04.033
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A??1-42, Annals of Neurology, vol.6, issue.6, pp.68-825, 2010. ,
DOI : 10.1002/ana.22315
Relationship between CSF ioaakes of Alzheiee's disease aad ates of egioal otial thiig i ADNI data, J ,
Clinical diagnosis of Alzheiee's disease: epot of the NINCDS-ADRDA Work Group under the auspices of Depaateet of Health aad Huaa Seeies Task Foe o Alzheiee's Disease, Neuuolog, pp.939-944, 1984. ,
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-746, 2007. ,
DOI : 10.1016/S1474-4422(07)70178-3
Reeisig the defiitio of Alzheiee's disease: a ee leeio ,
The diagnosis of ild ogitie ipaiet due to Alzheiee's disease: eeoeedatios fo the Natioal Institute on Aging-Alzheiee's Assoiatio okggoups o diagosti guidelies fo Alzheiee's disease ,
The diagosis of deeetia due to Alzheiee's disease: eoeedatios ffo the Natioal Institute on Aging-Alzheiee's Assoiatio okggoups o diagosti guidelies fo Alzheiee's disease ,
An operational approach to National Institute on Aging-Alzheiee's Assoiatio iteeia for preclinical Alzheimer disease, Ann. Neurol, pp.71-765, 2012. ,
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease, Neurology, vol.78, issue.20, pp.78-1576, 2012. ,
DOI : 10.1212/WNL.0b013e3182563bbe
Neuronal injury biomarkers are not dependent on ?-amyloid in normal ederly, Ann. Neurol ,
Neuroimaging results impose ee iees o Alzheiee's disease--the role of amyloid revised, Mol. Neurobiol, pp.45-153, 2012. ,
Commentary on « Recommendations from the National Institute on Aging- Alzheiee's Assoiatio okgoups o diagosti guidelies fo Alzheiee's disease. » Addessig the halleege of Alzheiee's disease i the st eetuu, Alzheiees Deeeet, pp.335-337, 2011. ,
A?-independent processes: rethinking preclinical AD, Nature Review Neurology ,
Serial PIB aad MRI i oal, ild ogitie ipaieet aad Alzheiee's disease: ipliatios fo seeueeee of pathologial eeets i Alzheiee's disease ,
Longitudinal patterns of ?amyloid deposition in nondemented older adults, Arch. Neurol, pp.68-644, 2011. ,
Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data, Annals of Neurology, vol.66, issue.5, pp.857-861, 2011. ,
DOI : 10.1002/ana.22608
Is it time for biomarker-based diagnostic criteria for prodromal Alzheiee's disease?, Alzheiees Res Thee ,
Early dementia diagnosis and the risk of suicide and euthanasia, Alzheimer's & Dementia, vol.6, issue.1, pp.75-82, 2010. ,
DOI : 10.1016/j.jalz.2009.04.1229
To Know or Not to Know: Ethical Issues Related to Early Diagnosis of Alzheimer's Disease, International Journal of Alzheimer's Disease, vol.37, issue.1 ,
DOI : 10.1002/gps.1576
Estiatig aad disslosig the isk of deeelopig Alzheiee's disease: challenges, controversies and future directions, Future Neurol, vol.5, pp.501-517, 2010. ,
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease, Neurology, vol.77, issue.15, pp.77-1487, 2011. ,
DOI : 10.1212/WNL.0b013e318232ac1a
Ethical considerations of biomarker use in neurodegenerative diseases--a ase stud of Alzheiee's disease ,
Principles and practice of screening for disease, 1968. ,
Comparison of 18F-FDG and PiB PET in Cognitive Impairment, Journal of Nuclear Medicine, vol.50, issue.6, p.50, 2009. ,
DOI : 10.2967/jnumed.108.058529
Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study, Neurology, vol.76, issue.12, pp.76-1085, 2011. ,
DOI : 10.1212/WNL.0b013e318212015e
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease, Arch. Neurol, pp.68-1404, 2011. ,
Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals, Neurobiology of Aging, vol.34, issue.3, pp.822-831, 2013. ,
DOI : 10.1016/j.neurobiolaging.2012.06.014